XML 441 R119.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments - Schedule of Changes in Assets, Level 3 Fair Value, Investments Held at Fair Value (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of financial assets [line items]      
Balance at beginning of period $ 575,738    
Cash purchase of Vor preferred shares 0 $ 19,961 $ 0
Gain/(loss) on changes in fair value 77,945    
Balance at end of period 479,146 575,738  
Vor      
Disclosure of financial assets [line items]      
Balance at end of period 6,012    
Vedanta      
Disclosure of financial assets [line items]      
Balance at end of period 14,153    
Level 3 of fair value hierarchy      
Disclosure of financial assets [line items]      
Balance at beginning of period 29,094    
Balance at end of period 29,472 29,094  
Investments held at fair value      
Disclosure of financial assets [line items]      
Balance at beginning of period 251,892    
Balance at end of period 317,841 251,892  
Investments held at fair value | Level 3 of fair value hierarchy      
Disclosure of financial assets [line items]      
Balance at beginning of period 12,593 239,533 206,892
Reclassification of Akili to level 1 investment   (128,764)  
Gain/(loss) on changes in fair value (9,299) (31,253) 65,505
Balance at end of period 24,872 12,593 239,533
Investments held at fair value | Level 3 of fair value hierarchy | Vor      
Disclosure of financial assets [line items]      
Cash purchase of Vor preferred shares     500
Reclassification of Vor from level 3 to level 1     $ (33,365)
Investments held at fair value | Level 3 of fair value hierarchy | Sonde      
Disclosure of financial assets [line items]      
Deconsolidation of subsidiary   11,168  
Investments held at fair value | Level 3 of fair value hierarchy | Gelesis      
Disclosure of financial assets [line items]      
Gelesis Earn-out Shares received in the SPAC exchange   14,214  
Exchange of Gelesis preferred shares to Gelesis common shares   $ (92,303)  
Investment in Gelesis 2023 Warrants 1,121    
Investments held at fair value | Level 3 of fair value hierarchy | Vedanta      
Disclosure of financial assets [line items]      
Deconsolidation of subsidiary $ 20,456